ArticleJCI insight2025

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

Shaghayegh Nouruzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.